Effects of Interrupting Sedentary Behavior With High - or Low Intensity PA on CVD - and Cardiometabolic Riskfactors, and Cognitive Performance.
1 other identifier
interventional
25
1 country
1
Brief Summary
The knowledge gap on sedentary behavior and sedentary breaks includes whether detrimental effects of sedentary behavior can be fully attenuated by 1.) sedentary breaks 2.) physical activity or 3.) both combined. Specifically, when breaking sedentary time which physical activity pattern- and intensity modifies the negative effects of sedentary behavior on glucose- and lipid metabolism? This lack of quantitative evidence calls for prospective experimental studies investigating the physiological and biological impacts of sedentary behavior, as well as the effectiveness of different strategies to reduce sedentary time. Thus, quantifying effects of the intensity, frequency, volume of sedentary breaks and/or physical activity on predefined outcomes is of importance. Aims: Our primary aims are to investigate the effects of breaking up sedentary time on glucose- and lipid metabolism and thus examine whether physical activity intensity breaks during sedentary breaks matter. Specifically, the aims of the PhD-project are to provide knowledge on the following questions: • How does high- or low physical activity intensity sedentary breaks acutely influence glucose- and lipid metabolism under iso-caloric conditions?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2023
CompletedFirst Submitted
Initial submission to the registry
January 6, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedJanuary 21, 2026
January 1, 2026
3 years
January 6, 2023
January 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total (tAUC)- and incremental areas under the curve (iAUC) for glucose
During each of the trial conditions blood samples will be taken in the fasted state in the morning and then every 30 minutes of the trials (total 420minutes) through a peripheral venous catheter. We will then calculate the iAUC for glucose for each of the trial condition and compare the different trial conditions with the control condition
The iAUC for glucose will be assessed during the procedure and consist of measures every 30 minute throughout the trial (420 minutes)
Secondary Outcomes (5)
tAUC and iAUC analyses for insulin
The iAUC for the secondary outcomes will be assessed during the procedure and consist of measures every 30 minute throughout the trial (420 minutes)
tAUC and iAUC analyses for c-peptide
The iAUC for the secondary outcomes will be assessed during the procedure and consist of measures every 30 minute throughout the trial (420 minutes)
tAUC and iAUC analyses for triglycerides
The iAUC for the secondary outcomes will be assessed during the procedure and consist of measures every 30 minute throughout the trial (420 minutes)
tAUC and iAUC analyses for lipids
The iAUC for the secondary outcomes will be assessed during the procedure and consist of measures every 30 minute throughout the trial (420 minutes)
Cognitive function and performance
The cognitive measures will be performed during the procedure (at approx 400 minutes)
Study Arms (3)
Control trial
EXPERIMENTALSitting from 8 am until 3pm.
High intensity sedentary breaks
EXPERIMENTALPhysical activity on 80-85% of individual VO2max every hour. Modality: Hill walking/jogging on treadmill.
Low intensity sedentary breaks
EXPERIMENTALPhysical activity on 25-30% of individual VO2max every hour. Modality: Hill walking on treadmill.
Interventions
Interrupting sitting with walking/jogging at either high -or low physical activity intensity.
Eligibility Criteria
You may qualify if:
- Predominantly sedentary occupation.
- Physical activity: equal or less tham 150 minutes /week
- Nonobese. Central adiposity: Waist circumference equal or less than 102 cm for men and equal or less than \< 88 cm for women. BMI \< 30 km·m2
You may not qualify if:
- Shift-work
- Smoking
- Pregnancy
- Current use of medication, except from hormonal contraceptives.
- No presence of any co-morbidity (e.g. diabetes type 2, cardiovascular or cardiorespiratory disease, or other conditions known to affect carbohydrate and lipid metabolism - thyroid-, -liver or kidney).
- Systolic /diastolic resting blood pressure: \> 140/90 mmHg
- Fasting blood glucose concentration: \> 6.1 mmol/L
- Abnormal total cholesterol, LDL, LDL or triglyceride concentrations (\> 50% above recommendations)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian School of Sport Scienceslead
- The Research Council of Norwaycollaborator
Study Sites (1)
Norwegian School of Sports Sciences
Oslo, Oslo County, 0806, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jostein Steene-Johennessen, Professor
Norwegian School of Sports Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 6, 2023
First Posted
February 2, 2023
Study Start
January 2, 2023
Primary Completion
December 20, 2025
Study Completion
December 20, 2025
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share